Novo Nordisk (NVO) ROE US GAAP (year values)

2021 2021 2022 2022 2023   LTM ? CAGR 5 years ?
ROE, % ? 67.5% 67.5% 66.5% 66.5% 78.5%   55.9%  
Changes by years, y/y, % +1pp 0pp -1pp 0pp +12pp     +1.1%

Novo Nordisk. ROE, %

Novo Nordisk. ROE, changes, pp

Novo Nordisk (NVO) ROE US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
ROE, % ? 81.0% 78.5% 90.3% 79.9% 74.6%   55.9%
Changes by years, y/y, % +12pp +12pp +65pp +13pp -6pp    
Changes by quarters, q/q, % +14pp -2pp +12pp -10pp -5pp    

Novo Nordisk. ROE, %

Novo Nordisk. ROE, changes, pp

Novo Nordisk. ROE, changes, pp